Advertisement

Topics

Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer

20:00 EDT 18 Oct 2017 | AAAS

(ViewRay) A retrospective review of 42 inoperable, locally-advanced pancreatic cancer patients treated at four institutions found that higher delivered radiation doses enabled via ViewRay's MRIdian adaptive MR-guided radiation therapy showed a near doubling of median overall survival (27.8 months compared to 14.8 months) and resulted in favorably lower toxicities (0 percent compared to 15.8 percent grade 3 or higher toxicity).

Original Article: Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer

NEXT ARTICLE

More From BioPortfolio on "Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer"

Quick Search
Advertisement
 

Relevant Topics

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...